ArticleSubstance use & misuse2018
At the Expense of a Life: Race, Class, and the Meaning of Buprenorphine in Pharmaceuticalized "Care".
Article in Substance use & misuse, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
19 citing papers in PubMed, 1 synthesis or guideline pooled it, 46 citations in OpenAlex.
- A systematic review of patients' and providers' perspectives of medications for treatment of opioid use disorder.Journal of substance abuse treatment · 2020Pooled it
- Using structured analysis and design technique to characterize barriers and facilitators to outpatient care coordination after emergency department-initiated buprenorphine.Journal of substance use and addiction treatment · 2026Article
- "There's always somebody that you can identify with": a qualitative study of patient perspectives on buprenorphine group medical visits.Addiction science & clinical practice · 2025Article
- Trends in cannabis use disorder and treatment by race and ethnicity, 2002-2019.Frontiers in psychiatry · 2025Article
- The role of recovery peer navigators in retention in outpatient buprenorphine treatment: a retrospective cohort study.Annals of medicine · 2024Article
- Association of economic and racial segregation with restricted buprenorphine dispensing in U.S. community pharmacies.Drug and alcohol dependence reports · 2024Article
- Perceptions around medications for opioid use disorder among a diverse sample of U.S. adults.Journal of substance use and addiction treatment · 2024Article
- Perspectives on APRN prescribing of medications for opioid use disorder: Key barriers remain.Journal of substance use and addiction treatment · 2024Article
- Prevalence and correlates of experiencing drug-related discrimination among people who use drugs presenting at emergency department at high risk of opioid overdose.Addictive behaviors reports · 2023Article
- Awareness, perception and utilization of a mobile health clinic by people who use drugs.Annals of medicine · 2022Article
- Racial and Ethnic Disparities in Buprenorphine and Extended-Release Naltrexone Filled Prescriptions During the COVID-19 Pandemic.JAMA network open · 2022Article
- A systematic literature review of patient perspectives of barriers and facilitators to access, adherence, stigma, and persistence to treatment for substance use disorder.Exploratory research in clinical and social pharmacy · 2021Review
- Growing racial/ethnic disparities in buprenorphine distribution in the United States, 2007-2017.Drug and alcohol dependence · 2021Article
- Quality of Buprenorphine Care for Insured Adults With Opioid Use Disorder.Medical care · 2021Article
- Voting with their feet: Social factors linked with treatment for opioid use disorder using same-day buprenorphine delivered in California hospitals.Drug and alcohol dependence · 2021Article
- "The elephant in the room;" a qualitative study of perinatal fears in opioid use disorder treatment in Southern Appalachia.BMC pregnancy and childbirth · 2021Article
- On my own terms: Motivations for self-treating opioid-use disorder with non-prescribed buprenorphine.Drug and alcohol dependence · 2020Article
- The Lived Experience of Medication for Opioid Use Disorder: Qualitative Metasynthesis.Journal of addictions nursingArticle
- "I'm Clean and Sober, But Not Necessarily Free": Perceptions of Buprenorphine Among Patients in Long-Term Treatment.Substance abuseArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 3 institutions in 1 country.
Funding
Abstract
BACKGROUND/
objectiveOffice-based buprenorphine maintenance has been legalized and promoted as a treatment approach that not only expands access to care, but also reduces the stigma of addiction treatment by placing it in a mainstream clinical setting. At the same time, there are differences in buprenorphine treatment utilization by race, ethnicity, and socioeconomic status.
methodsThis article draws on qualitative data from interviews with 77 diverse patients receiving buprenorphine in a primary care clinic and two outpatient substance dependence clinics to examine differences in patients' experiences of stigma in relation their need for psychosocial supports and services.
resultsManagement of stigma and perception of social needs varied significantly by ethnicity, race and SES, with white educated patients best able to capitalize on the medical focus and confidentiality of office-based buprenorphine, given that they have other sources of support outside of the clinic, and Black or Latino/a low income patients experiencing office-based buprenorphine treatment as isolating.
conclusionDrawing on Agamben's theory of "bare life," and on the theory of intersectionality, the article argues that without attention to the multiple oppressions and survival needs of addiction patients who are further stigmatized by race and class, buprenorphine treatment can become a form of clinical abandonment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.